Conclusion
The world's largest study for Atrial Fibrillation, The SAFER-study, has been expanded to carry out and evaluate how distance screening can be done without any physical meeting needed, The first COVID-19 secured patient in Great Britain have now been screened. While not estimate or stock moving per se, we see this as proof of fast and agile adoption to current market conditions as well as downside protection on sales estimates if additional lockdowns would occur, due to the possibility to continue the arrhythmia investigations in distance
LÄS MER
